Opko Health Inc (NASDAQ: OPK) stock jumped 3.50% on Monday to $1.48 against a previous-day closing price of $1.43. With 2.99 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.1 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.5000 whereas the lowest price it dropped to was $1.4200. The 52-week range on OPK shows that it touched its highest point at $2.24 and its lowest point at $1.00 during that stretch. It currently has a 1-year price target of $4.42. Beta for the stock currently stands at 1.84.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OPK was up-trending over the past week, with a rise of 15.62%, but this was up by 14.73% over a month. Three-month performance dropped to -12.94% while six-month performance fell -1.33%. The stock lost -9.20% in the past year, while it has gained 18.40% so far this year. A look at the trailing 12-month EPS for OPK yields -0.28 with Next year EPS estimates of -0.22. For the next quarter, that number is -0.10. This implies an EPS growth rate of 43.48% for this year and 15.38% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 3.51%.
Float and Shares Shorts:
At present, 772.65 million OPK shares are outstanding with a float of 414.71 million shares on hand for trading. On Oct 30, 2023, short shares totaled 29.92 million, which was 3.87% higher than short shares on Sep 28, 2023. In addition to Dr. Phillip Frost Ph.D. as the firm’s Chairman & CEO, Dr. Jane H. Hsiao M.B.A., Ph.D. serves as its Vice Chairman & Chief Technical Officer.
Through their ownership of 23.82% of OPK’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 6.89% of OPK, in contrast to 48.90% held by mutual funds. Shares owned by individuals account for 17.59%. As the largest shareholder in OPK with 4.99% of the stake, The Vanguard Group, Inc. holds 38,584,986 shares worth 38,584,986. A second-largest stockholder of OPK, BlackRock Fund Advisors, holds 29,683,350 shares, controlling over 3.84% of the firm’s shares. KSM Mutual Funds Ltd. is the third largest shareholder in OPK, holding 10,055,027 shares or 1.30% stake. With a 1.65% stake in OPK, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 12,728,537 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.29% of OPK stock, is the second-largest Mutual Fund holder. It holds 9,933,158 shares valued at 12.42 million. iShares Russell 2000 ETF holds 1.22% of the stake in OPK, owning 9,459,063 shares worth 11.82 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OPK since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OPK analysts setting a high price target of $8.50 and a low target of $2.00, the average target price over the next 12 months is $4.42. Based on these targets, OPK could surge 474.32% to reach the target high and rise by 35.14% to reach the target low. Reaching the average price target will result in a growth of 198.65% from current levels.
Summary of Insider Activity:
Insiders traded OPK stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 84 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 2,885,245 while 0 shares were sold.